Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025 ...

Cost of revenues was RMB35.7 million (US$4.9 million) for the three months ended March 31, 2025, representing a 10.6% decrease from RMB39.9 million for the same period in 2024, primarily due to a ...

CHICAGO, June 05, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society ...

“Summer is the perfect time to embrace crisp, sessionable brews with bright flavors,” said Prinz Pinakatt, Chief Growth ...

Under the terms of the MSA, OBI grants TegMine rights to utilize OBI’s GlycOBI ® ADC enabling technologies, powered by EndoSymeOBI ® and HYPrOBI ®, to identify ADC therapeutics candidates for ...

Some of these preclinical data with Addex GABAB PAM drug candidate will be presented on June 7, 2025 at the 10 th American Cough Conference, in Dulles, Virginia by Dr Mikhail Kalinichev, Head of ...

Bondholders can access the invitations to the two bondholder meetings scheduled for Wednesday, June 25, 2025, including the terms of the resolution and additional information about the meeting, as ...

About Syndax Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj ® (revumenib), an ...

Of the shares covered by the Options, one-third will vest on each of the first three anniversaries of the grant date, in each case for so long as the grantee provides continuous service to Anika ...

The inducement grant consisted of time-based restricted stock units (“RSUs”) for 33,600 shares of Intellia’s common stock, with one-third of such RSUs vesting on June 1, 2026, 2027 and 2028.

The fireside chat session is scheduled for Monday, June 9, in Miami, FL, at 9:20 a.m. ET. A live and archived webcast of the session will be accessible under “Events & Presentations” in the Investors ...

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to ...